Table 1: Effects of Isoquercetin and or Estrogen on GSH, MDA levels and SOD activity in ovariectomized rats.


Treatment Parameter

GSH (µmol/g tissue) MDA (nmol/g tissue) SOD (U/mg protein)
Control 4.85 ± 0.17 20.93 ± 0.69 2.85 ± 0.11
Sham 4.43 ± 012 20.88 ± 0.17 2.67 ± 0.09
OVX 2.8 a, b ± 0.15 33.35 a, b ± 1.5 3.5 a, b ± 0.08
OVX + Isoquercitrin 4.26 c ± 0.25 21.56 c ± 1.1 2.77 c ± 0.06
OVX + Estrogen 3.6 a, b, c ± 0.2 22.4 c ± 0.9 3.1 a, b ± 0.05
OVX + Isoqurecitrin + Estrogen 4.1 c ± 0.18 19.5 c ± 0.6 2.3 c ± 0.07

Data presented are means ± SEM. (n = 8).

aP < 0.05; significantly different from control group.

bP < 0.05; significantly different from OVX group. ANOVA followed by Tukey-Kramer post hoc test.

a: significant difference from control group.

b: significant difference from sham group.

c: significant difference from ovx (ovariectomized) non treated group.

d: significant difference from ovx (ovariectomized) isoquercetin treated group.

e: significant difference from ovx (ovariectomized) estrogen treated group.